Gabelli Funds’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-690,000
| Closed | -$594K | – | 1159 |
|
|
2019
Q4 | $594K | Hold |
690,000
| – | – | ﹤0.01% | 922 |
|
|
2019
Q3 | $387K | Hold |
690,000
| – | – | ﹤0.01% | 986 |
|
|
2019
Q2 | $359K | Hold |
690,000
| – | – | ﹤0.01% | 1023 |
|
|
2019
Q1 | $311K | Hold |
690,000
| – | – | ﹤0.01% | 1031 |
|
|
2018
Q4 | $331K | Hold |
690,000
| – | – | ﹤0.01% | 1029 |
|
|
2018
Q3 | $366K | Hold |
690,000
| – | – | ﹤0.01% | 1045 |
|
|
2018
Q2 | $345K | Hold |
690,000
| – | – | ﹤0.01% | 1050 |
|
|
2018
Q1 | $292K | Sell |
690,000
-10,000
| -1% | -$4.02K | ﹤0.01% | 1071 |
|
|
2017
Q4 | $266K | Hold |
700,000
| – | – | ﹤0.01% | 1063 |
|
|
2017
Q3 | $252K | Hold |
700,000
| – | – | ﹤0.01% | 1068 |
|
|
2017
Q2 | $266K | Hold |
700,000
| – | – | ﹤0.01% | 1079 |
|
|
2017
Q1 | $315K | Hold |
700,000
| – | – | ﹤0.01% | 1050 |
|
|
2016
Q4 | $266K | Hold |
700,000
| – | – | ﹤0.01% | 1075 |
|
|
2016
Q3 | $189K | Hold |
700,000
| – | – | ﹤0.01% | 1123 |
|
|
2016
Q2 | $168K | Hold |
700,000
| – | – | ﹤0.01% | 1134 |
|
|
2016
Q1 | $80K | Hold |
700,000
| – | – | ﹤0.01% | 1120 |
|
|
2015
Q4 | $79K | Hold |
700,000
| – | – | ﹤0.01% | 1125 |
|
|
2015
Q3 | $133K | Buy |
700,000
+200,000
| +40% | +$68K | ﹤0.01% | 1060 |
|
|
2015
Q2 | $350K | Sell |
500,000
-6,198
| -1% | -$4.29K | ﹤0.01% | 1006 |
|
|
2015
Q1 | $343K | Sell |
506,198
-100,000
| -16% | -$69.9K | ﹤0.01% | 1004 |
|
|
2014
Q4 | $479K | Sell |
606,198
-289,600
| -32% | -$198K | ﹤0.01% | 984 |
|
|
2014
Q3 | $417K | Sell |
895,798
-204,200
| -19% | -$99.1K | ﹤0.01% | 1000 |
|
|
2014
Q2 | $550K | Sell |
1,099,998
-90,000
| -8% | -$43.5K | ﹤0.01% | 953 |
|
|
2014
Q1 | $369K | Sell |
1,189,998
-358,602
| -23% | -$133K | ﹤0.01% | 986 |
|
|
2013
Q4 | $527K | Sell |
1,548,600
-253,100
| -14% | -$306K | ﹤0.01% | 935 |
|
|
2013
Q3 | $3.64M | Sell |
1,801,700
-10,000
| -0.6% | -$19K | 0.02% | 625 |
|
|
2013
Q2 | $3.44M | Buy |
+1,811,700
| New | +$3.18M | 0.02% | 608 |
|
Gabelli Funds's GCVRZ Position: Q1 2020 in Review
Gabelli Funds sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 690,000 shares — an estimated $594K sold.
Gabelli Funds first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $3.64M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Gabelli Funds reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Gabelli Funds sold 690,000 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $594K.
- Gabelli Funds first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Gabelli Funds's Sanofi Contingent Value Rights position peaked at $3.64M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Gabelli Funds's 13F filing for Q1 2020, filed 14 May 2020.